The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Welcome stories


23 November 2010
22/11/2010 The London Stock Exchange welcomes 3D Diagnostic Imaging plc to AIM

The London Stock Exchange today welcomed the admission of 3D Diagnostic Imaging to trading on AIM.  3D Diagnostic Imaging owns the protected rights to a technology platform with a number of significant potential commercial applications.  The Group’s subsidiary, CarieScan Ltd has launched the Company’s first commercial product, the CarieScan PRO (“PRO”), an easy to use, highly accurate handheld device for the early detection and monitoring of dental caries (tooth decay). Early detection of hidden tooth decay enables remedial treatment to be undertaken to reverse the damage to affected teeth and can thus avoid the need for fillings. The Group’s ultimate objective is to develop, market and commercialise a series of products based on its technology with a range of different applications, such as the early detection of osteoporosis, malignant melanomas, the state of health monitoring of battery systems for electric vehicles or early detection of corrosion within building materials.

3D raised £2.71million (before expenses) by way of a placing of 45,248,318 Ordinary Placing Shares at 6 pence per share with existing and new investors. The market capitalisation of 3D Diagnostic Imaging at the Placing Price is £10.23 million.

3d

On announcement of the Placing and Admission to AIM, James Noble, Chairman of 3D Diagnostic Imaging, commented: "3D has reached an exciting stage in its development where its strategic objectives can be more readily achieved by a listing on AIM, providing the Group with access to additional funding to achieve our growth aspirations.

“Having recently appointed Patterson Dental to distribute the CarieScan PRO in the USA and Canada, the proceeds of the placing enable us to scale-up manufacture of the PRO to target these substantial markets.”

.

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds